| Identification | Back Directory | [Name]
BMS639623 | [CAS]
675122-44-8 | [Synonyms]
BMS639623 PON9OFP69G CHEMBL399495 UNII-PON9OFP69G Urea, N-[(1R,2S)-3-[(3S)-3-[(4-fluorophenyl)methyl]-1-piperidinyl]-2-hydroxy-1-methylpropyl]-N'-[3-(1-methyl-1H-tetrazol-5-yl)phenyl]- | [Molecular Formula]
C25H32FN7O2 | [MOL File]
675122-44-8.mol | [Molecular Weight]
481.57 |
| Hazard Information | Back Directory | [Uses]
BMS-639623 is a potent and orally activeCCR3 antagonist with an IC50 of 0.3 nM. BMS-639623 picomolar inhibition potency against eosinophil chemotaxis (IC50=38 pM). BMS-639623 can be used for the research of asthma[1]. | [IC 50]
CCR3: 0.3 nM (IC50) | [References]
[1] Santella JB 3rd, et al. From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis. Bioorg Med Che DOI:10.1016/j.bmcl.2007.11.067 |
|
|